Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas

Surgery

Volumn 126, Issue 6, 1999, Pages 1183-1187

  Farnebo, Filip ^a,b   Svensson, Ann ^a,b   Thompson, Norman W ^a,b   Bäckdahl, Martin ^a,b   Grimelius, Lars ^a,b   Larsson, Catharina ^a,b   Farnebo, Lars Ove ^a,b   Sandelin, Kerstin ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MESSENGER RNA; PROTEINASE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CELL HYBRIDIZATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPARATHYROIDISM; PARATHYROID CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS;

EID: 0032739384     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2099.101420     Document Type: Article

References (25)

1. 1. Sandelin K, Thompson NW, Bondeson L. Metastatic parathyroid carcinoma: dilemmas in management. Surgery 1991;110:978-86.
2. 2. Shane E, Bilezikian JP. Parathyroid carcinoma: a review of 62 patients. Endocr Rev 1982;3:218-26.
3. 3. Levin KE, Galante M, Clark OH. Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery 1987;101:649-60.
4. 4. Anderson BJ, Samaan NA, Vassilopopulou-Sellin R, Ordonez NG, Hickey RC. Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery 1983;94:906-15.
5. 5. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine 1992;71:197-205.
6. 6. Vetto JT, Brennan MF, Woodruff J, Burt M. Parathyroid carcinoma: diagnosis and clinical history. Surgery 1993;114:882-92.
7. 7. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
8. 8. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
9. 9. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.
10. 10. Zedenius J, Ståhle-Backdahl M, Enberg U, Grimeluis L, Larsson C, Wallin G, et al. Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA. World J Surg 1996;20:101-6.
11. 11. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 1991;59:467-73.
12. 12. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60.
13. 13. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995;55:434-9.
14. 14. Kataoka H, DeCastro R, Zucker S, Biswas C. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72kDa gelatinase. Cancer Res 1993;53:3154-8.
15. 15. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
16. 16. Cryns VL, Rubio M-P, Thor AD, Louis DN, Arnold A. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 1994;78:1320-4.
17. 17. Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL Jr, et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994;330:757-61.
18. 18. Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferate activity in parathyroid tumors as detected by Ki-67 immunohistostaining. Hum Pathol 1995;26:135-8.
19. 19. Lloyd RV, Carney AJ, Ferreiro JA, Long J, Thompson GB, van Heerden JA, et al. Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocr Pathol 1995;4:279-87.
20. 20. Farnebo F, Auer G, Farnebo L-O, Teh BT, Twigg, S, Aspenblad U, et al: Evaluation of RB and Ki-67 immunostaining as diagnostic markers in benign and malignant parathyroid disease. World J Surg 1999;23:68-74.
21. 21. Bondesson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 1993;17:820-9.
22. 22. Sandelin K, Tullgren O, Farnebo L-O: Clinical course of metastatic parathyroid cancer. World J Surg 1994;18:594-9.
23. 23. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988;263:6579-87.
24. 24. Dinnen JS, Greenwood RH, Jones JH, Walker DA, Williams DE. Parathyroid carcinoma in familial hyperparathyroidism. J Clin Pathol 1977;30:966-75.
25. 25. Wassif W, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjöld M, et al. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 1993;77:1485-9.